Page 79 - 《中国药房》2025年17期

酸、胆汁酸等代谢途径发挥作用。后续仍需进一步通过 tics and disease[J]. Nat Genet，2021，53（12）：1712-1721.
实验验证这些核心基因与免疫代谢途径的具体关系，并 [11] CHEN J X，LI Y，ZHANG Y B，et al. Nonlinear relation‐
探讨其在临床治疗中的潜在价值。 ship between high-density lipoprotein cholesterol and car‐
参考文献 diovascular disease：an observational and Mendelian ran‐
domization analysis[J]. Metabolism，2024，154：155817.
[ 1 ] HEIANZA Y，WANG X，KOU M H，et al. Circulating di‐
[12] YE C J，LIU D，CHEN M L，et al. Mendelian randomiza‐
methylguanidino valeric acid，dietary factors，and risk of
tion evidence for the causal effect of mental well-being on
coronary heart disease[J]. Cardiovasc Res，2024，120
healthy aging[J]. Nat Hum Behav，2024，8（9）：1798-1809.
（16）：2147-2154.
[13] LIAO J，BEI L Y，NIE P B，et al. DNA methylation-
[ 2 ] MCEVOY J W，JENNINGS C，KOTSEVA K，et al. Varia‐
regulated ZDHHC13 promotes the progression of
tion in secondary prevention of coronary heart disease：the
Parkinson’s disease[J]. Mol Neurobiol，2025，62（7）：
INTERASPIRE study[J]. Eur Heart J，2024，45（39）：
9162-9169.
4184-4196.
[14] ABRAMOWITZ S A，BOULIER K，KEAT K，et al.
[ 3 ] ARNOLD N，BLAUM C，GOßLING A，et al. C-reactive
Evaluating performance and agreement of coronary heart
protein modifies lipoprotein（a）-related risk for coronary
disease polygenic risk scores[J]. JAMA，2025，333（1）：
heart disease：the BiomarCaRE project[J]. Eur Heart J，
60-70.
2024，45（12）：1043-1054.
[15] CHEN R，CHEN T，WANG T Q，et al. Tongmai yangxin
[ 4 ] NORLAND K，SCHAID D J，NADERIAN M，et al. Asso‐
pill reduces myocardial No-reflow via endothelium-
ciations of self-reported race，social determinants of
dependent NO-cGMP signaling by activation of the
health，and polygenic risk with coronary heart disease[J]. J
cAMP/PKA pathway[J]. J Ethnopharmacol，2021，267：
Am Coll Cardiol，2024，84（22）：2157-2166.
113462.
[ 5 ] 王显，安冬青，中华中医药学会介入心脏病学分会代表
[16] SHEN Y C，DONG Z G，FAN F F，et al. Targeting
编制组. 通脉养心丸治疗冠心病心绞痛（气阴两虚证）临
cytokine-like protein FAM3D lowers blood pressure in hy‐
床应用专家共识[J]. 中华中医药学刊，2021，39（9）：
pertension[J]. Cell Rep Med，2023，4（6）：101072.
253-258.
[17] MOSER C，GOSSELÉ K A，BALAZ M，et al. FAM3D：a
[ 6 ] FAN Y Y，MAN S L，LI H F，et al. Analysis of bioactive
gut secreted protein and its potential in the regulation of
components and pharmacokinetic study of herb-herb
glucose metabolism[J]. Peptides，2023，167：171047.
interactions in the traditional Chinese patent medicine
[18] LV J L，PAN C，CAI Y P，et al. Plasma metabolomics re‐
Tongmai yangxin pill[J]. J Pharm Biomed Anal，2016，
veals the shared and distinct metabolic disturbances asso‐
120：364-373.
ciated with cardiovascular events in coronary artery
[ 7 ] JONES T，FENG J J，LUYTIES O，et al. TFIIH kinase
disease[J]. Nat Commun，2024，15：5729.
CDK7 drives cell proliferation through a common core
[19] HAAS B W，FILKOWSKI M M，COCHRAN R N，et al.
transcription factor network[J]. Sci Adv，2025，11（9）：
Epigenetic modification of OXT and human sociability[J].
eadr9660.
Proc Natl Acad Sci USA，2016，113（27）：E3816-E3823.
[ 8 ] YANG Q Q，YANG Q，WU X Y，et al. Sex-stratified
[20] TAKAYA K， KISHI K. Regulation of ENPP5， a
genome-wide association and transcriptome-wide
senescence-associated secretory phenotype factor，pre‐
Mendelian randomization studies reveal drug targets of
vents skin aging[J]. Biogerontology，2024，25（3）：
heart failure[J]. Cell Rep Med，2024，5（2）：101382.
529-542.
[ 9 ] MA Z，FREY N，RANGREZ A Y. Blood plasma metabo‐
[21] LIN Z T，PAN W. A robust cis-Mendelian randomization
lites and heart failure risk：insights from Mendelian ran‐
method with application to drug target discovery[J]. Nat
domization analysis[J]. Eur Heart J，2024，45（Suppl.1）：
Commun，2024，15：6072.
ehae666.1205.
（收稿日期：2025-03-17 修回日期：2025-08-11）
[10] FERKINGSTAD E，SULEM P，ATLASON B A，et al.
（编辑：胡晓霖）
Large-scale integration of the plasma proteome with gene-

中国药房 2025年第36卷第17期 China Pharmacy 2025 Vol. 36 No. 17 · 2153 ·